Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Several organizations have developed frameworks to systematically assess the value of new drugs. These organizations include the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), the Institute for Clinical and Economic Review (ICER), and the National Com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health Jg. 20; H. 2; S. 200 - 205
Hauptverfasser:	Bentley, Tanya G.K., Cohen, Joshua T., Elkin, Elena B., Huynh, Julie, Mukherjea, Arnab, Neville, Thanh H., Mei, Matthew, Copher, Ronda, Knoth, Russell, Popescu, Ioana, Lee, Jackie, Zambrano, Jenelle M., Broder, Michael S.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.02.2017 Elsevier Science Ltd
Schlagworte:	Antineoplastic Agents - standards Cancer Confidence intervals Convergent validity Decision making Decision Support Techniques Drugs Evaluation Feedback Health care inter-rater reliability Internal Medicine Lung cancer Medical decision making Medical Oncology Oncology Pilot Projects Reliability Reproducibility of Results Sensitivity analysis Validity Value value frameworks Value-Based Purchasing convergent validity value frameworks oncology inter-rater reliability
ISSN:	1098-3015, 1524-4733, 1524-4733
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!